AG
AMED

Algert Global’s Amedisys AMED Stock Holding History

Algert Global’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,260
Closed -$395K – 1177
2025
Q1 		$395K Buy
+4,260
New +$393K 0.01% 958
2024
Q4 		– Sell
-3,292
Closed -$318K – 1165
2024
Q3 		$318K Hold
3,292
– – 0.01% 986
2024
Q2 		$302K Buy
+3,292
New +$305K 0.01% 1114
2022
Q2 		– Sell
-1,831
Closed -$315K – 1196
2022
Q1 		$315K Buy
+1,831
New +$274K 0.02% 949
2021
Q4 		– Sell
-4,140
Closed -$617K – 958
2021
Q3 		$617K Buy
+4,140
New +$861K 0.08% 451
2020
Q2 		– Sell
-3,410
Closed -$626K – 415
2020
Q1 		$626K Buy
+3,410
New +$607K 0.26% 140
2019
Q2 		– Sell
-13,771
Closed -$1.7M – 343
2019
Q1 		$1.7M Sell
13,771
-13,037
-49% -$1.64M 0.97% 16
2018
Q4 		$3.14M Buy
26,808
+11,269
+73% +$1.33M 0.88% 19
2018
Q3 		$1.94M Buy
15,539
+1,403
+10% +$155K 0.42% 88
2018
Q2 		$1.21M Buy
+14,136
New +$1.04M 0.25% 149
2016
Q3 		– Sell
-12,700
Closed -$641K – 363
2016
Q2 		$641K Sell
12,700
-275
-2% -$13.9K 0.26% 153
2016
Q1 		$627K Buy
12,975
+3,155
+32% +$122K 0.24% 165
2015
Q4 		$386K Buy
9,820
+1,840
+23% +$73.6K 0.18% 209
2015
Q3 		$303K Buy
+7,980
New +$337K 0.17% 215
2014
Q1 		– Sell
-42,290
Closed -$619K – 311
2013
Q4 		$619K Buy
+42,290
New +$681K 0.17% 193

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Algert Global's AMED Position: Q2 2025 in Review

Algert Global sold out of Amedisys (AMED) in Q2 2025, closing a stake of 4,260 shares — an estimated $395K sold.

Algert Global first reported a position in AMED in Q4 2013 and held it in 15 quarters. The position peaked at $3.14M in Q4 2018. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Algert Global reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Algert Global sold 4,260 Amedisys shares in Q2 2025, an estimated $395K.
  • Algert Global first reported a position in Amedisys in Q4 2013 and held it in 15 quarters.
  • Algert Global's Amedisys position peaked at $3.14M in Q4 2018.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.